Praxis precision medicines announces upcoming ulixacaltamide presentations & events

Ulixacaltamide essential tremor end-of-phase 2 meeting with fda scheduled for june 2023 ulixacaltamide essential tremor end-of-phase 2 meeting with fda scheduled for june 2023

PRAX Ratings Summary

PRAX Quant Ranking